Phio Pharmaceuticals Corp (NASDAQ:PHIO) has a beta value of 0.42 and has seen 1.62 million shares traded in the last trading session. The company, currently valued at $13.04M, closed the last trade at $2.73 per share which meant it gained $0.03 on the day or 1.11% during that session. The PHIO stock price is -258.61% off its 52-week high price of $9.79 and 64.47% above the 52-week low of $0.97. If we look at the company’s 10-day average daily trading volume, we find that it stood at 17.17 million shares traded. The 3-month trading volume is 3.19 million shares.
Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information
Sporting 1.11% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PHIO stock price touched $2.73 or saw a rise of 12.78%. Year-to-date, Phio Pharmaceuticals Corp shares have moved 51.67%, while the 5-day performance has seen it change 65.45%. Over the past 30 days, the shares of Phio Pharmaceuticals Corp (NASDAQ:PHIO) have changed 102.22%. Short interest in the company has seen 78709.0 shares shorted with days to cover at 0.77.
Phio Pharmaceuticals Corp (PHIO) estimates and forecasts
The company’s shares have lost -1.09% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 66.30% over the past 5 years.
PHIO Dividends
Phio Pharmaceuticals Corp is expected to release its next earnings report on 2025-Mar-30 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders
Insiders own 0.29% of the company shares, while shares held by institutions stand at 16.95% with a share float percentage of 17.00%. Investors are also buoyed by the number of investors in a company, with Phio Pharmaceuticals Corp having a total of 15.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Feb 28, 2025 , the former fund manager holds about 0.09% shares in the company for having 4.24 shares of worth $11586.0 while later fund manager owns 2.71 shares of worth $7390.0 as of Dec 31, 2024 , which makes it owner of about 0.06% of company’s outstanding stock.
